US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist

5.540
+0.070+1.28%

Close Jul 12 16:00 ET

5.540
0.0000.00%

Post 19:58 ET

455.60MMarket Cap-2676P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-39.43%-49.87M

25.47%-132.18M

47.39%-22.24M

26.13%-35.46M

-2.29%-38.71M

27.34%-35.77M

-8.27%-177.35M

-22.24%-42.27M

-17.70%-48M

2.85%-37.85M

Net income from continuing operations

-26.34%-61.95M

30.49%-153.22M

68.93%-18.87M

19.21%-45.02M

24.63%-40.29M

2.93%-49.04M

-14.51%-220.43M

-46.58%-60.74M

-42.59%-55.73M

3.26%-53.45M

Operating gains losses

----

--0

--1.58M

----

Depreciation and amortization

-8.74%1.41M

-4.31%6.06M

-7.04%1.47M

-5.61%1.51M

-3.63%1.54M

-0.90%1.54M

25.41%6.34M

4.37%1.58M

34.79%1.6M

34.40%1.6M

Other non cash items

----

--1.6M

----

-134.77%-177K

Change In working capital

-24.13%4.8M

-119.50%-1.59M

-167.27%-8.09M

777.31%4.56M

-158.08%-4.4M

153.01%6.33M

138.19%8.18M

555.55%12.02M

103.90%520K

604.09%7.57M

-Change in receivables

102.77%9.94M

-3.36%-5.04M

-54.53%-7.77M

-122.93%-136K

-410.17%-2.04M

543.71%4.9M

-184.38%-4.88M

-31,306.25%-5.03M

641.25%593K

93.26%659K

-Change in prepaid assets

-203.15%-1.61M

-43.80%-197K

-118.02%-968K

-86.83%160K

-17.06%-947K

1,673.74%1.56M

-103.67%-137K

-119.16%-444K

129.58%1.22M

-189.59%-809K

-Change in payables and accrued expense

-577.01%-4.15M

-82.37%2.62M

-89.05%1.5M

1,119.35%4.74M

-176.49%-4.49M

120.66%870K

380.36%14.87M

92.41%13.68M

89.85%-465K

2,136.46%5.87M

-Change in other current assets

-76.95%1.34M

141.67%6.63M

75.70%-4.58M

227.17%2.37M

17.69%3.03M

162.51%5.8M

-309.90%-15.92M

-830.19%-18.84M

-174.25%-1.87M

-70.21%2.58M

-Change in other current liabilities

89.38%-723K

-131.93%-5.61M

-83.55%3.73M

-346.88%-2.58M

101.65%48K

-111.76%-6.81M

267.41%17.57M

786.66%22.65M

166.69%1.04M

65.33%-2.91M

-Change in other working capital

----

85.32%-3.33M

--0

1,545.70%2.18M

Cash from discontinued investing activities

Operating cash flow

-39.43%-49.87M

25.47%-132.18M

47.39%-22.24M

26.13%-35.46M

-2.29%-38.71M

27.34%-35.77M

-8.27%-177.35M

-22.24%-42.27M

-17.70%-48M

2.85%-37.85M

Investing cash flow

Cash flow from continuing investing activities

-120.39%-4.75M

-103.27%-3.73M

328.28%62.84M

-215.23%-102.82M

424.39%12.98M

-58.73%23.27M

309.43%114.07M

-20.53%-27.53M

324.97%89.23M

-183.53%-4M

Net PPE purchase and sale

-1.68%-1.87M

-15.10%-4.72M

-109.46%-1.31M

61.07%-239K

-117.10%-1.33M

18.15%-1.84M

48.60%-4.1M

78.07%-624K

73.81%-614K

77.29%-614K

Net investment purchase and sale

-111.45%-2.87M

-99.16%988K

338.43%64.15M

-214.18%-102.58M

522.52%14.32M

-57.17%25.11M

354.18%118.17M

-34.55%-26.9M

340.75%89.84M

-145.20%-3.39M

Cash from discontinued investing activities

Investing cash flow

-120.39%-4.75M

-103.27%-3.73M

328.28%62.84M

-215.23%-102.82M

424.39%12.98M

-58.73%23.27M

309.43%114.07M

-20.53%-27.53M

324.97%89.23M

-183.53%-4M

Financing cash flow

Cash flow from continuing financing activities

192K

9,093.07%118.04M

-16.96%514K

31,923.16%117.53M

-99.54%1.28M

-41.44%619K

-96.79%80K

-97.85%367K

Net common stock issuance

----

--117.08M

--0

----

--0

----

Proceeds from stock option exercised by employees

--192K

-25.23%960K

-16.96%514K

--0

21.53%446K

--0

-96.07%1.28M

-41.38%619K

-96.79%80K

-97.85%367K

Cash from discontinued financing activities

Financing cash flow

--192K

9,093.07%118.04M

-16.96%514K

--0

31,923.16%117.53M

--0

-99.54%1.28M

-41.44%619K

-96.79%80K

-97.85%367K

Net cash flow

Beginning cash position

-12.29%127.53M

-29.89%145.4M

-59.73%86.42M

29.67%224.69M

-38.12%132.9M

-29.89%145.4M

44.47%207.4M

-18.65%214.58M

-49.29%173.28M

-40.14%214.76M

Current changes in cash

-335.37%-54.43M

71.18%-17.87M

159.43%41.11M

-434.79%-138.28M

321.30%91.8M

-269.80%-12.5M

-197.12%-62M

-22.74%-69.18M

152.99%41.3M

-142.80%-41.48M

End cash Position

-44.99%73.1M

-12.29%127.53M

-59.73%86.42M

29.67%224.69M

-38.12%132.9M

-29.89%145.4M

-18.65%214.58M

-49.29%173.28M

Free cash flow

-37.59%-51.74M

24.56%-136.9M

45.11%-23.55M

26.57%-35.7M

-4.07%-40.04M

26.94%-37.61M

-5.64%-181.47M

-14.62%-42.9M

-12.73%-48.62M

7.64%-38.48M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-39.43%-49.87M	25.47%-132.18M	47.39%-22.24M	26.13%-35.46M	-2.29%-38.71M	27.34%-35.77M	-8.27%-177.35M	-22.24%-42.27M	-17.70%-48M	2.85%-37.85M
Net income from continuing operations	-26.34%-61.95M	30.49%-153.22M	68.93%-18.87M	19.21%-45.02M	24.63%-40.29M	2.93%-49.04M	-14.51%-220.43M	-46.58%-60.74M	-42.59%-55.73M	3.26%-53.45M
Operating gains losses	----	----	----	--0	--0	--1.58M	----	----	----	----
Depreciation and amortization	-8.74%1.41M	-4.31%6.06M	-7.04%1.47M	-5.61%1.51M	-3.63%1.54M	-0.90%1.54M	25.41%6.34M	4.37%1.58M	34.79%1.6M	34.40%1.6M
Other non cash items	----	--1.6M	----	----	----	----	----	----	----	-134.77%-177K
Change In working capital	-24.13%4.8M	-119.50%-1.59M	-167.27%-8.09M	777.31%4.56M	-158.08%-4.4M	153.01%6.33M	138.19%8.18M	555.55%12.02M	103.90%520K	604.09%7.57M
-Change in receivables	102.77%9.94M	-3.36%-5.04M	-54.53%-7.77M	-122.93%-136K	-410.17%-2.04M	543.71%4.9M	-184.38%-4.88M	-31,306.25%-5.03M	641.25%593K	93.26%659K
-Change in prepaid assets	-203.15%-1.61M	-43.80%-197K	-118.02%-968K	-86.83%160K	-17.06%-947K	1,673.74%1.56M	-103.67%-137K	-119.16%-444K	129.58%1.22M	-189.59%-809K
-Change in payables and accrued expense	-577.01%-4.15M	-82.37%2.62M	-89.05%1.5M	1,119.35%4.74M	-176.49%-4.49M	120.66%870K	380.36%14.87M	92.41%13.68M	89.85%-465K	2,136.46%5.87M
-Change in other current assets	-76.95%1.34M	141.67%6.63M	75.70%-4.58M	227.17%2.37M	17.69%3.03M	162.51%5.8M	-309.90%-15.92M	-830.19%-18.84M	-174.25%-1.87M	-70.21%2.58M
-Change in other current liabilities	89.38%-723K	-131.93%-5.61M	-83.55%3.73M	-346.88%-2.58M	101.65%48K	-111.76%-6.81M	267.41%17.57M	786.66%22.65M	166.69%1.04M	65.33%-2.91M
-Change in other working capital	----	----	----	----	----	----	85.32%-3.33M	--0	--0	1,545.70%2.18M
Cash from discontinued investing activities
Operating cash flow	-39.43%-49.87M	25.47%-132.18M	47.39%-22.24M	26.13%-35.46M	-2.29%-38.71M	27.34%-35.77M	-8.27%-177.35M	-22.24%-42.27M	-17.70%-48M	2.85%-37.85M
Investing cash flow
Cash flow from continuing investing activities	-120.39%-4.75M	-103.27%-3.73M	328.28%62.84M	-215.23%-102.82M	424.39%12.98M	-58.73%23.27M	309.43%114.07M	-20.53%-27.53M	324.97%89.23M	-183.53%-4M
Net PPE purchase and sale	-1.68%-1.87M	-15.10%-4.72M	-109.46%-1.31M	61.07%-239K	-117.10%-1.33M	18.15%-1.84M	48.60%-4.1M	78.07%-624K	73.81%-614K	77.29%-614K
Net investment purchase and sale	-111.45%-2.87M	-99.16%988K	338.43%64.15M	-214.18%-102.58M	522.52%14.32M	-57.17%25.11M	354.18%118.17M	-34.55%-26.9M	340.75%89.84M	-145.20%-3.39M
Cash from discontinued investing activities
Investing cash flow	-120.39%-4.75M	-103.27%-3.73M	328.28%62.84M	-215.23%-102.82M	424.39%12.98M	-58.73%23.27M	309.43%114.07M	-20.53%-27.53M	324.97%89.23M	-183.53%-4M
Financing cash flow
Cash flow from continuing financing activities	192K	9,093.07%118.04M	-16.96%514K	0	31,923.16%117.53M	0	-99.54%1.28M	-41.44%619K	-96.79%80K	-97.85%367K
Net common stock issuance	----	--117.08M	--0	--0	----	----	--0	--0	--0	----
Proceeds from stock option exercised by employees	--192K	-25.23%960K	-16.96%514K	--0	21.53%446K	--0	-96.07%1.28M	-41.38%619K	-96.79%80K	-97.85%367K
Cash from discontinued financing activities
Financing cash flow	--192K	9,093.07%118.04M	-16.96%514K	--0	31,923.16%117.53M	--0	-99.54%1.28M	-41.44%619K	-96.79%80K	-97.85%367K
Net cash flow
Beginning cash position	-12.29%127.53M	-29.89%145.4M	-59.73%86.42M	29.67%224.69M	-38.12%132.9M	-29.89%145.4M	44.47%207.4M	-18.65%214.58M	-49.29%173.28M	-40.14%214.76M
Current changes in cash	-335.37%-54.43M	71.18%-17.87M	159.43%41.11M	-434.79%-138.28M	321.30%91.8M	-269.80%-12.5M	-197.12%-62M	-22.74%-69.18M	152.99%41.3M	-142.80%-41.48M
End cash Position	-44.99%73.1M	-12.29%127.53M	-12.29%127.53M	-59.73%86.42M	29.67%224.69M	-38.12%132.9M	-29.89%145.4M	-29.89%145.4M	-18.65%214.58M	-49.29%173.28M
Free cash flow	-37.59%-51.74M	24.56%-136.9M	45.11%-23.55M	26.57%-35.7M	-4.07%-40.04M	26.94%-37.61M	-5.64%-181.47M	-14.62%-42.9M	-12.73%-48.62M	7.64%-38.48M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall